EvlaBio
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- $25M
Investors
- 5
About EvlaBio
EvlaBio focuses on developing therapies for cardiovascular and renal conditions. Founded in 2022 in Zurich, Switzerland, the company has engaged in 1 deal to date.Venture.EvlaBio specializes in addressing unmet needs within the cardiorenal space through innovative therapeutic solutions. The company’s core product offerings focus on advanced treatments designed to improve outcomes for patients suffering from cardiovascular and renal conditions. Their products are directed towards healthcare professionals and institutions, including hospitals and clinics primarily within the European and North American markets.EvlaBio's revenue generation model is structured around direct partnerships with healthcare providers and institutions. The company engages in B2B transactions, supplying its therapeutic products to hospitals and healthcare facilities that integrate these solutions into their treatment protocols. Typical agreements may involve long-term supply contracts, ensuring consistent availability of their flagship products while facilitating training and support for medical staff. The company plans to further enhance its product lineup with upcoming innovations in therapeutic solutions targeting the cardiorenal sector. Additionally, EvlaBio is strategizing to expand its market presence in both European and North American regions, aiming for broader reach and accessibility of its products by the end of 2026.
Who invested in EvlaBio
5 investors across 1 round
See all investors in EvlaBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 2, 2025
Amount
$25M
Investors
Questions about EvlaBio
Who invested in EvlaBio?
EvlaBio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EvlaBio raised?
EvlaBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EvlaBio last raise money?
EvlaBio's most recent round on record is a Seed, in Jul 2025.
What does EvlaBio do?
EvlaBio focuses on developing therapies for cardiovascular and renal conditions.
Where is EvlaBio headquartered?
EvlaBio is headquartered in Zurich, Switzerland.
Which VCs invest in companies like EvlaBio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at EvlaBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like EvlaBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.